Skip to content

Prospective cohort study of EZH2 protein expression in predicting carcinogenesis in patients with oral leukoplakia

Prospective cohort study of EZH2 protein expression in predicting carcinogenesis in patients with oral leukoplakia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039992
Enrollment
Unknown
Registered
2020-11-17
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral leukoplakia

Interventions

non canceration group:Nil
leukoplakia canceration group:Nil

Sponsors

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Over 20 years old (including 20 years old), under 80 years old (including 80 years old), regardless of gender; (2) The white plaque was histopathologically confirmed as oral mucosal white plaque; (3) No other induced differentiation treatments (including oral/ external use of retinoic acid) before going to our hospital. (4) If the pregnancy test of female subjects of childbearing age is negative, they shall agree to use effective contraceptive measures to ensure that they will not become pregnant during the test and within 3 months after the cessation of treatment.

Exclusion criteria

Exclusion criteria: (1) Definite distant metastasis or occurrence of other malignant tumors; (2) persons suffering from mental illness and unable to cooperate with the treatment; (3) The function of important organs is impaired and life is in danger; (4) Patients with abnormal coagulation function and bleeding tendency; (5) Pregnant or lactating women; (6) Participated in other clinical trials within the previous 30 days.

Design outcomes

Primary

MeasureTime frame
EZH2 protein expression;

Countries

China

Contacts

Public ContactHaiwen Zhou

Shanghai Jiao Tong University, School of Medicine, Shanghai Ninth People's Hospital

haiwen39@126.com+86 13916864387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026